Moxian Appoints Conglin Deng As CEO

Internet media marketing services provider Moxian (BVI) Inc (NASDAQ:MOXC) appointed existing company director Conglin (Forrest) Deng as its…

byAnusuya Lahiri

September 20, 2021

1 minute read

Internet media marketing services provider Moxian (BVI) Inc (NASDAQ:MOXC) appointed existing company director Conglin (Forrest) Deng as its CEO, with immediate effect.
Deng served as the GM of Beijing Jiuteng Investment Limited since 2016.
Price Action: MOXC shares traded lower by 6.96% at $6.82 in the premarket session on the last check Monday.

Needham Maintains Buy on Harmony Biosciences, Raises Price Target to $65

By Benzinga Newsdesk

Today, 10:39 AM

Needham analyst Ami Fadia maintains Harmony Biosciences (NASDAQ:HRMY) with a Buy and raises the price target from $60 to $65.

HRMY

AstraZeneca’s Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease

By Vandana Singh

Today, 10:39 AM

AstraZeneca Plc (NASDAQ:AZN) shared new and prolonged follow-up results from the Phase 3 CHAMPION-MG trial open-label extension (OLE) of Ultomiris (ravulizumab-cwvz)…

AZN

Guggenheim Initiates Coverage On Taysha Gene Therapies with Buy Rating, Announces Price Target of $28

By Benzinga Newsdesk

Today, 10:39 AM

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Buy rating and announces Price Target of $28.

TSHA

American Express And 3 Other Stocks Sold By Insiders

By Lisa Levin

Today, 10:39 AM

The annual inflation rate in the US increased to 7.5% in January, the highest level since February 1982 and well above analysts' estimates of 7.3%. Investors, meanwhile, focused on some notable insider trades.

AXP

Moxian Appoints Conglin Deng As CEO

Related Posts

Needham Maintains Buy on Harmony Biosciences, Raises Price Target to $65

AstraZeneca’s Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease

Guggenheim Initiates Coverage On Taysha Gene Therapies with Buy Rating, Announces Price Target of $28

American Express And 3 Other Stocks Sold By Insiders